Kvalme og opkastning induceret af medicinsk kræftbehandling

Translated title of the contribution: Nausea and vomiting induced by antineoplastic therapy

Peter Clausager Petersen, Christina H. B. Ruhlmann, Jørn Herrstedt

Research output: Contribution to journalJournal articleResearchpeer-review


Nausea and vomiting are a persistent burden on cancer patients undergoing antineoplastic therapy, and adherence to guideline-specific prophylactic therapy is essential to minimise the risk. Nausea is more challenging to prevent than vomiting. This review summarises the choices of relevant drugs. Olanzapine is effective against nausea, but sedation can be a problem. There seems to be no major differences in effect or tolerability between different serotonin receptor antagonists and different neurokinin receptor antagonists. Consequently, the choice of drug should be based on price, risk of interactions and simple administration.
Translated title of the contributionNausea and vomiting induced by antineoplastic therapy
Original languageDanish
Article numberV02190115
JournalUgeskrift for Laeger
Issue number8
Publication statusPublished - 2020


Dive into the research topics of 'Nausea and vomiting induced by antineoplastic therapy'. Together they form a unique fingerprint.

Cite this